Barclays
ULBI icon

Barclays’s Ultralife ULBI Stock Holding History

Barclays’s Portfolio ULBI Stock Details ULBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2
Closed -$11 – 5453
2025
Q4 		$11 Sell
2
-1,580
-100% -$9.75K ﹤0.01% 5155
2025
Q3 		$10.8K Buy
1,582
+1,580
+79,000% +$12K ﹤0.01% 5014
2025
Q2 		$18 Sell
2
-10,209
-100% -$60.5K ﹤0.01% 5145
2025
Q1 		$54.9K Sell
10,211
-5,022
-33% -$34.1K ﹤0.01% 4592
2024
Q4 		$113K Buy
15,233
+1,838
+14% +$15.1K ﹤0.01% 4566
2024
Q3 		$121K Buy
13,395
+2,355
+21% +$24.3K ﹤0.01% 4518
2024
Q2 		$117K Sell
11,040
-101
-0.9% -$1.07K ﹤0.01% 3832
2024
Q1 		$98.2K Sell
11,141
-13,409
-55% -$109K ﹤0.01% 4444
2023
Q4 		$167K Buy
24,550
+11,581
+89% +$95.1K ﹤0.01% 4489
2023
Q3 		$127K Buy
+12,969
New +$104K ﹤0.01% 3502
2021
Q4 		– Sell
-1,317
Closed -$9K – 4749
2021
Q3 		$9K Buy
1,317
+277
+27% +$2.23K ﹤0.01% 4540
2021
Q2 		$9K Sell
1,040
-6,557
-86% -$56.4K ﹤0.01% 4681
2021
Q1 		$63K Buy
7,597
+4,664
+159% +$33.1K ﹤0.01% 4158
2020
Q4 		$19K Sell
2,933
-1,097
-27% -$6.92K ﹤0.01% 4682
2020
Q3 		$24K Sell
4,030
-830
-17% -$5.45K ﹤0.01% 4866
2020
Q2 		$34K Buy
+4,860
New +$35.5K ﹤0.01% 5069
2019
Q4 		– Sell
-10
Closed – – 6833
2019
Q3 		$0 Buy
+10
New +$86 ﹤0.01% 7145
2019
Q2 		– Sell
-82,978
Closed -$852K – 7289
2019
Q1 		$852K Buy
82,978
+71,545
+626% +$642K ﹤0.01% 3585
2018
Q4 		$77K Buy
11,433
+6,923
+154% +$50.3K ﹤0.01% 5225
2018
Q3 		$37K Buy
4,510
+4,475
+12,786% +$41.8K ﹤0.01% 6235
2018
Q2 		$0 Sell
35
-1
-3% -$10 ﹤0.01% 7298
2018
Q1 		$0 Buy
+36
New +$279 ﹤0.01% 7341

Other funds holding ULBI

VWA
Visionary Wealth Advisors O'fallon, Illinois $2.26B AUM 19.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
THC
Truffle Hound Capital Bethesda, Maryland $386M AUM 57.88% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Barclays's ULBI Position: Q1 2026 in Review

Barclays sold out of Ultralife (ULBI) in Q1 2026, closing a stake of 2 shares — an estimated $11 sold.

Barclays first reported a position in ULBI in Q1 2018 and held it in 22 quarters. The position peaked at $852K in Q1 2019. 50 funds tracked by Wall St. Rank hold ULBI as of Q1 2026.

  • Barclays reported no remaining Ultralife position as of Q1 2026 after selling out during the quarter.
  • Barclays sold 2 Ultralife shares in Q1 2026, an estimated $11.
  • Barclays first reported a position in Ultralife in Q1 2018 and held it in 22 quarters.
  • Barclays's Ultralife position peaked at $852K in Q1 2019.
  • 50 funds tracked by Wall St. Rank held Ultralife as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.